Objective. Patients with chronic widespread pain (CWP) have been reported to have a greater prevalence of mental disorders and somatization than that found in the general population, but the true association between CWP and mental disorders is unknown. In this study, we investigated whether there is an increased prevalence of mental disorder in people with CWP from the general population. We also describe the psychiatric diagnoses associated with CWP.
The diagnosis of somatoform disorders (particularly somatization disorder) is uncommon in the general population but has been prominent in some reports of chronic pain patients attending clinics (1, 4) . Published population surveys of the prevalence of mental disorders have not assessed pain routinely, nor have they assessed organic state or consultation for physical symptoms or disability, all of which contribute to the diagnosis of somatoform disorders. Assessments of somatization disorder based on physical symptom counts (16) are of limited value in this context, because higher somatic (including pain) symptom counts are also associated with depression and anxiety (17, 18) . In the general population, the relationship between chronic pain and somatoform disorders, identified in accordance with standardized diagnostic criteria, remains uncertain.
To address these issues, surveys require the use of standardized criteria and assessments for both chronic pain and mental disorders. The American College of Rheumatology (ACR) has defined classification criteria for fibromyalgia in terms of CWP and multiple tender points (19) .
The evidence that mental disorders are associated with chronic pain, including fibromyalgia, in both clinic patients and the general population is inconclusive, and the relationship between separate diagnostic groups and CWP remains to be examined. In this study, we tested the hypothesis that subjects with CWP in the general population had higher rates of mental disorder than subjects without CWP. In addition, we determined the prevalence of psychiatric diagnostic groups including mood, anxiety, and somatoform disorders and examined the association of these diagnostic groups by comparing persons with CWP, other pain, and no pain.
SUBJECTS AND METHODS

Design and population.
A population-based case-control study involving prevalent cases of CWP was performed. A population sample of 3,004 subjects age 18-65 years was randomly selected from a general practice register in the south Manchester, UK, area. This is a mixed but relatively affluent sociodemographic area with high employment levels compared with other parts of the region. The general practice register provides a convenient sampling frame for community subjects, since >95% of the population in the UK is registered with a general practice (20) .
Each subject was sent a postal questionnaire and, if necessary, a reminder postcard and then a further copy of the questionnaire.
Pain assessment.
The questionnaire survey, conducted in 1995, inquired about any pain experienced during the previous month that had persisted for at least 24 hours. Subjects were asked if they had been aware of this pain for >3 months. Four line drawings of the body were included (front, back, and sides), and subjects were asked to indicate the sites of their pain. These methods for determining the duration and location of pain have been used successfully in previous studies (21, 22) .
On the basis of the information provided by the questionnaire, subjects were categorized into 3 groups. The first group of subjects was classified as having CWP using the criteria for this component of the fibromyalgia syndrome as defined by the ACR (19) . Briefly, pain must have been present for >3 months in at least 2 contralateral quadrants and in the axial skeleton. The other-pain group included all subjects who experienced pain that had lasted for >24 hours during the previous month, but who did not meet the ACR criteria for CWP.
The no-pain group comprised subjects who did not report any pain for >24 hours in the past month.
Psychiatric assessment.
The 12-item version of the General Health Questionnaire (GHQ-12) (23) was used to identify potential cases of mental illness, serving as the initial screening process in a 2-stage assessment of mental disorders. In validation studies, threshold scores ranging from 1/2 to 3/4 have been shown to discriminate between cases and noncases (23) , depending on the purpose of screening. For the present study, we deliberately chose a low GHQ threshold of 2 to provide high sensitivity at the cost of relatively low specificity (those who score <2 are very unlikely to have a mental disorder).
Interviews.
Subjects completing the questionnaire were asked whether they would be willing to be interviewed. A random sample (the size of which was dictated by resources of those subjects scoring >1 on the GHQ (the screened-positive group) and agreeing to further contact (74%) was asked to participate in the interview. We used the 10th edition of the Present State Examination (PSE-10), a highly structured and standardized psychiatric interview included in the Schedules for Clinical Assessment in Neuropsychiatry (24) . The PSE-10 assesses the presence and severity of symptoms of adult mental disorders in accordance with requirements for diagnoses included in the 10th revision of the International Classification of Diseases (ICD-10) (25) . Diagnoses were made using a computer program that applies the ICD-10 algorithms (24) . The PSE-10 has been shown to have good interrater reliability and validity. The psychiatrist (SM) was unaware of the subject's GHQ-12 score (apart from its being above the threshold) or pain group status.
Somatic symptoms that were elicited at interview and that might have contributed to the diagnosis of somatoform disorders were evaluated further to determine whether they were due to organic disorders. General practitioners' records were reviewed. Symptoms were attributed to physical disorders if there were clinical or investigative findings to support this. Two research psychiatrists (SM and SB) repeated this procedure independently with a proportion of records, and interrater reliability was almost perfect.
Analysis.
The association between CWP and mental disorder was modeled using logistic regression, adjusting for possible confounders including age and sex. Inevitably, in population-based studies involving intensive, time-consuming interviews on personal issues, there is an important proportion of individuals for whom interview data are lacking because of nonparticipation. In the current study, we attempted in our analysis to estimate the magnitude of any consequent bias using a weighted logistic regression (26) . This technique assigns sampling weights to the interviewed subgroup, such that those subjects represent all those who were eligible to be interviewed. The advantage of this over other estimating techniques is that the variance and standard errors and, hence, the confidence intervals can be calculated directly from the logistic model. Since the number of subjects included in the calculation is not inflated, the estimates are conservative. The theory and assumptions underlying this approach are given in Appendix A.
RESULTS
From the 3,004 subjects to whom questionnaires were mailed, 1,953 completed responses were received (Table 1) . On examination of the electoral roll, it was found that 402 nonresponders (264 men and 138 women) were not registered as living at the address of record at their general practice and were therefore unlikely to have received the questionnaire. Excluding these subjects, the total number of subjects was 2,602 (1,182 men and 1,420 women), and the overall adjusted response rate was 75%. As is usual with postal surveys, a higher proportion of women (79%) than men (71%) returned the questionnaire (P < 0.001 by chi-square test), with the highest response rate (89%) from women age 18-32 years. Table 1 . Age and sex of responders (first time and reluctant) and nonresponders to questionnaire* Of those who responded, 60.5% responded to the first mailed questionnaire, while the remainder (referred to subsequently as reluctant responders) responded following a postal reminder or further questionnaire. The distribution of the main variables measured is shown in Table 2 . Reluctant responders were more likely to be younger males. This group also had slightly higher GHQ scores, although there was no difference in the prevalence of CWP. 710 subjects (36%) screened positive on the GHQ and were therefore candidates for the psychiatric interview. A resource-constrained random sample of 526 subjects was chosen for interview. Of these, 301 subjects (57%) were interviewed. There were several differences between those subjects who were interviewed and those 409 (184 not selected, 225 refusing interview) who were not. Interviewed subjects tended to be older, female, and have higher GHQ scores (Table 3) . Table 3 . Characteristics of interviewed and noninterviewed eligible subjects * *See Table 2 for definitions.
Within this interviewed subgroup, 97 persons (32%) were diagnosed as having a mental disorder. The prevalence of mental disorder was higher in females (n = 69, 36%) than in males (n = 28, 25%) and twice as common in women age 53-65 years (n = 21, 42%) than in men age 53-65 years (n = 4, 17%). The rate of mental disorder was higher in the 67 persons with CWP (n = 30, 45%) compared with the 234 without CWP (n = 67, 29%). The odds of having a mental disorder in the CWP group were 2.0 (95% confidence interval [95% CI] 1.1-3.6) relative to those without CWP.
For subjects who were interviewed, univariate analysis (separately for those with and without CWP) indicated that GHQ score and response category were important factors in predicting which subjects were likely to be diagnosed as having a mental disorder (Table 4) . Also, we were unable to exclude important influences of age and sex. However, there were no significant interactions. Since exposures to these influences differed between interviewed subjects and remaining eligible subjects (Table 3) , weighted logistic regression was used to reflect the sampling fraction, with respect to these potentially important explanatory variables, to estimate the relationship between CWP and mental disorder in all the questionnaire responders (see Appendix A). The adjusted odds of having a mental disorder in the presence of CWP (relative to those without CWP) for all 1,953 subjects who responded were 3.14 (95% CI 1.74-5.64). Using these data, we estimated an overall population prevalence of mental disorder of 11.7% (95% CI 9.8-14.1) in the questionnaire responders. The prevalence in those with CWP was 16.9%, versus 6.5% in those without CWP. It was important to extrapolate from the available data to the original population sample, including questionnaire nonresponders. We therefore assumed that the relationship between CWP and mental disorder among the 25% of subjects who did not respond to the questionnaire resembled that among the subjects who were reluctant to respond to the original questionnaire, after allowing for age and sex (see Appendix A). We therefore performed further logistic regression weighting the data from the 1,953 responders to account for all subjects who were mailed questionnaires. The estimated odds of having a mental disorder in the presence of CWP relative to those without CWP were not altered (odds ratio 3.18, 95% CI 1.97-5.11). Using these data, we estimated the overall population prevalence of mental disorder in all subjects who were mailed questionnaires to be 11.9% (95% CI 9.4-15.1).
Most of the mental disorders diagnosed in the interviewed subsample were single or dual diagnoses of mood (depressive episodes and dysthymia) and/or anxiety disorders ( Table 5) . Diagnoses of somatoform disorders were limited to undifferentiated somatoform disorder, and occurred in only 3 subjects (1%), 2 in the CWP group and 1 in the other-pain group. Other diagnoses were mainly alcohol abuse, adjustment disorders, and neurasthenia, the last occurring only in the 2 pain groups. Since the number of subjects with individual diagnoses was small, weighted logistic regression analysis was conducted only on all those subjects with mood disorders and, separately, on those with anxiety disorders (including dual diagnoses). The findings indicated that depression and dysthymia were more strongly associated with the presence of CWP (Table 6 ). Table 5 . Number of diagnosed mental disorders by pain group in the interviewed subsample * * See Table 2 for definitions. † Includes subjects with diagnoses in >1 group of disorders. 
DISCUSSION
Subjects in clinical and population samples satisfying criteria for CWP have been described as having greater psychological distress and more depressive symptoms (21) and mental disorders (particularly depressive disorders and somatoform disorders) (3,4) than would be expected in the general population. These studies have not included structured, standardized assessments of mental disorders in the general population. In summary, this study has estimated for the first time the prevalence of mental disorder in people with and without CWP in a general population sample. Recognizing that nonparticipation is inevitable in this type of study, we have adjusted for possible sources of bias in our analysis. We estimate that 1) the prevalence of mental disorder in the population lies in the range of 11-12% and 2) persons with CWP have a 3-fold increased odds of mental disorder compared with persons not reporting such symptoms.
The goal of this study was to describe the association between mental disorder and musculoskeletal pain in the population as a whole. In all, 25% of the population estimated to have received a questionnaire did not respond. It is possible, but perhaps unlikely, that there is a difference in the association of pain with psychiatric disorder in those who did versus those who did not respond to the questionnaire. We evaluated this possibility by assuming that those who were reluctant responders might be more representative of the nonresponders, and compared the association of mental disorder with pain in reluctant responders with that in those who responded to the questionnaire the first time. No difference in this association was seen.
A more important consideration discussed at length in Appendix A is that those interviewed were not representative of those eligible for interview. We attempted to address this issue using the data available to permit the best prediction of the likely effect this nonparticipation bias would have on the occurrence of mental disorder in each of the pain groups. We allowed for the effects of differences in age, sex, GHQ score, and response category between participants and nonparticipants. However, there may have been other unmeasured confounders whose distribution varied between the 2 groups. Thus, our estimate of the strength of the association extrapolated to the population may still be subject to error.
The focus of this study was on estimating the true association between chronic pain and mental disorder in the population. Taking into account the impact of nonparticipation, our estimate of a 3-fold increase in the association provides the best overall prediction. The estimated prevalence of mental disorder in the mailed-to population, which was derived from the interview data, is similar to other general population estimates of mental disorders that have used standardized diagnostic classifications and structured interviews (27) (28) (29) . A more recent survey (30) found an overall prevalence of 16%; in the present study, the lower prevalence was probably determined by the relatively advantageous sociodemographic characteristics of our sample (e.g., higher-than-average socioeconomic status, lower unemployment rates). Considering all of this information together, it seems reasonable to conclude that the effect of any participation bias on the prevalence estimates is unlikely to be large.
As has been found with other population and primary care surveys, the majority of mental disorders diagnosed were mood and anxiety disorders, but only mood disorders were specifically associated with the CWP group. We cannot rule out the possibility that some cases of mood and anxiety disorders were missed due to the process of somatization, but this should have been minimized by the use of standardized diagnostic criteria and a structured psychiatric interview. This should also have mitigated the possibility of interviewer bias, since it was impossible in practice to blind the psychiatrist totally about pain status. Any such cases would be more likely to occur in the CWP group, since multiple pains are associated with depression (17) , reducing the prevalence found in this group. It is possible that the true excess morbidity in the CWP group may be somewhat greater than our estimate. It would also be of interest to investigate whether the relationships we found were related to the severity and chronicity of the pain complaint. However, this would require further study using validated approaches to assessing these dimensions of pain.
Somatoform disorders were uncommon, precluding any meaningful analysis. The prevalence was similar to that in other population surveys that use such restrictive criteria (16, 28) , and the 3 cases all occurred in subjects in the 2 pain groups. Somatoform disorders have been reported to be much more common in some studies of fibromyalgia patients (3, 4) . This difference is likely to be accounted for by less stringent criteria for diagnosis and ascertainment of somatoform disorders (16) , and also by the more severe disorders and extreme forms of illness behavior that occur in consulting subjects with fibromyalgia. Even so, it is notable that in the present study there were no diagnoses of persistent somatoform pain disorder. Although we were able to identify cases of chronic pain that, on scrutiny of medical records, could not be explained fully by a physical or physiologic disorder, the structured interview did not include data from collateral informants and may have failed to identify psychosocial causes. In addition, the ICD-10 algorithm excludes this diagnosis when pain thought to be psychogenic occurs in the course of a depressive disorder or is thought to be due to psychophysiologic mechanisms. Thus, less restrictive criteria for the diagnosis of somatoform disorders would be likely to result in the identification of more cases. Even so, it is clear that within the general population, ICD-10 diagnoses of most of the somatoform disorders (including somatization disorder, hypochondriacal disorder, and persistent somatoform pain disorder) and of dissociative disorder are uncommon in people with CWP.
In conclusion, one-sixth of subjects with CWP in the general population are also found to have a mental disorder when assessed by a trained psychiatrist using standardized, internationally accepted criteria and a structured psychiatric interview. Although the other subjects do not have a psychiatric diagnosis, the number of subjects with relatively high GHQ-12 scores indicates that many are distressed. A longitudinal prospective study is required to confirm the direction of any causal relationship between mental disorders and CWP. However, our findings should alert medical practitioners in primary and secondary care to look for and treat these disorders, and the routine use of a screening instrument such as the GHQ-12 might help to identify them.
